Cargando…
Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
INTRODUCTION: Vascular calcification is a common, serious and elusive complication of end-stage renal disease (ESRD). As a pro-calcifying risk factor, non-thyroidal illness may promote vascular calcification through a systemic lowering of vascular calcification inhibitors such as matrix-gla protein...
Autores principales: | Meuwese, Christiaan Lucas, Olauson, Hannes, Qureshi, Abdul Rashid, Ripsweden, Jonaz, Barany, Peter, Vermeer, Cees, Drummen, Nadja, Stenvinkel, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492991/ https://www.ncbi.nlm.nih.gov/pubmed/26147960 http://dx.doi.org/10.1371/journal.pone.0132353 |
Ejemplares similares
-
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
por: Chen, Zhimin, et al.
Publicado: (2019) -
Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease
por: Jaminon, Armand M. G., et al.
Publicado: (2020) -
Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
por: Golembiewska, Edyta, et al.
Publicado: (2020) -
Coronary artery calcification and aortic valve calcification in patients with kidney failure: a sex-disaggregated study
por: Ward, Liam J., et al.
Publicado: (2023) -
Scoring of medial arterial calcification predicts cardiovascular events and mortality after kidney transplantation
por: Erlandsson, Helen, et al.
Publicado: (2022)